- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Ino
Recent news which mentions Ino
Auction for top investors backing the first global real - Metaverse convergent platform
March 21, 2022
From PRLog
2 Beaten-Down Stocks That Aren't Worth the Trouble
March 16, 2022
From Motley Fool
Could Inovio Win On This 1 Vaccine Detail?
March 08, 2022
From Motley Fool
68 Biggest Movers From Yesterday
March 03, 2022
From Benzinga
Tickers
INO
From Motley Fool
41 Stocks Moving In Wednesday's Mid-Day Session
March 02, 2022
From Benzinga
From Benzinga
From Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
March 02, 2022
From Benzinga
Tickers
INO
From Motley Fool
From Benzinga
2 Money-Burning Biotech Stocks to Avoid
March 01, 2022
From Motley Fool
From Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Thinking About Buying Stock In AMC Entertainment, Romeo Power Or Inovio Pharmaceuticals?
February 24, 2022
From Benzinga
This Trend Is the Biggest Risk to Biotech Investors Right Now
February 21, 2022
From Motley Fool
Could Inovio Pharmaceuticals Become the Next Moderna?
February 02, 2022
From Motley Fool
2 Stocks to Avoid Like the Plague in 2022
January 29, 2022
From Motley Fool
Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals
January 21, 2022
Tickers
INO
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
January 21, 2022
From Benzinga
10 Biggest Price Target Changes For Friday
January 21, 2022
From Benzinga
Bill Gates Says Misinformation Related To Fauci, Himself Doesn't 'Make Sense,' Talks COVID-19 After Omicron
January 11, 2022
From Benzinga
Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals
January 11, 2022
From Motley Fool
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now
December 27, 2021
From Benzinga
Why Jim Cramer Likes MGM Growth Properties
December 21, 2021
From Benzinga
3 Ultra-Popular Stocks Expected to Increase Sales 981% to 5,569% in 2022
December 15, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.